Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Eko Brands, LLC v. Adrian Rivera Maynez Enterprises, Inc., Appeal Nos. 2018-2215, et al. (Fed. Cir. Jan. 13, 2020)
In this appeal from the Western District of Washington, the Federal Circuit addresses issues relating to claim construction, attorney’s fee awards, and willful infringement/enhanced damages. At the district court, following Eko’s default in ITC proceedings brought by Adrian Rivera Maynez (“ARM”) wherein ARM alleged that Eko infringed two claims of ARM’s ’320 patent, Eko asserted declaratory judgment claims of invalidity and non-infringement against those same claims of the ’320 patent, which relates to an adapter that could be used with Keurig coffee machines to allow them to function with not only “K-cups,” which are larger cup-shaped filter cartridges, but also with “pods,” which are small, flattened disk-shaped filter cartridges.
BioDelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Inc., Appeal Nos. 2019-1643, et al. (Fed. Cir. Jan. 13, 2020)
The Court denied en banc review of the panel decision in this case, and designated its denial precedential. Judge Newman dissented, making essentially the same arguments she made from her dissent in the panel decision. Our coverage of the panel decision is available here.
The opinion can be found here.
Written by: Scott Eads and Nika Aldrich, Schwabe, Williamson & Wyatt
Contributors: Erin M. Forbes
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…